title: Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?
authors.affiliation: Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, 1007 MB, Amsterdam, The Netherlands khn.deboer@vumc.nl.
authors.forename: Nanne K H
authors.initials: NK
authors.lastname: de Boer
authors.forename: Tim
authors.initials: T
authors.lastname: de Meij
authors.forename: Adriaan A
authors.initials: AA
authors.lastname: van Bodegraven
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000188:drug therapy*; D015122:Mercaptopurine / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy*; D011687:Purines / Q000009:adverse effects*; D012074:Remission Induction; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D005765:Gastrointestinal Agents; D011687:Purines; D015122:Mercaptopurine; D001379:Azathioprine; C030985:purine